期刊文献+

老年人心房颤动并发脑卒中40例临床分析 预览 被引量:5

Clinic Analysis of 40 Cases Senior Atrial Fibrillation Combined with Stroke
在线阅读 下载PDF
收藏 分享 导出
摘要 目的探讨老年人心房颤动并发脑卒中的危险因素及防治。方法将2002-2007年收治的216例老年心房颤动患者,分为脑卒中组40例、对照组(无脑卒中组)176例,采用病例对照研究的方法,分析病史、体征、辅助检查及合并疾病、用药情况。结果脑卒中组与对照组中,其脑卒中危险因素差异有统计学意义(P〈0.05)。结论年龄≥70岁、持续性房颤、高血压、糖尿病、左心房增大、未抗栓治疗是老年房颤并发脑卒中的高危危险因素。控制危险因素,合理应用抗凝、抗血小板药,可减少老年人心房颤动并发脑卒中的发生。 Objective To discuss the risk factors and prophylaxis senior atrial fibrillation with stroke. Methods 216 senior patients with atrial fibrillation were divided into study group(40 cases with stroke) and control group( 176 cases without stroke). The case-control study was used to analyze medical history, physical sign, accessory examination, coexistent disease and drug administering. Results There was significant difference in risk factors of stroke between the two groups ( P 〈 0.05 ). Conclusions The high risk factors of senior atrial fibrillation with stroke are advanced age (more than 70 years), persistent atrial fibrillation, hypertension, diabetes,left atrial enlargement and no antithrombotic treatment. The control of risk factors and properly use of antitbrombotic and antiplatelet treatment can reduce the occurrenee of senior atrial fibrillation with stroke.
作者 徐敏 XU Min( Department of Geriatrics,Huangshan People' s Hospital ,Anhui 245000, China)
出处 《中华全科医学》 2008年第10期 1042-1043,共2页 Applied Journal Of General Practice
关键词 老年人 心房颤动 脑卒中 抗凝治疗 Aged People Atrial fibrillation Stroke Antithrombotic treatment
  • 相关文献

参考文献8

二级参考文献27

  • 1李小鹰.老年心房颤动患者的抗血栓治疗[J].中华老年心脑血管病杂志,2005,7(2):73-75. 被引量:19
  • 2周红卫.非瓣膜性持续心房颤动患者抗血栓治疗临床调查[J].中国心脏起搏与心电生理杂志,2005,19(5):351-352. 被引量:3
  • 3Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the stroke council of the American Heart Association. Circulation, 2001, 103:163-182. 被引量:1
  • 4Laupacis A, Albers G, Dalen J, et al. Antithrombotic therapy in atrial fibrillation. Chest, 1998,114(5 Suppl):5795-5895. 被引量:1
  • 5Yamaguchi T. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. A multicenter, prospective, randomized trial. Stroke, 2000, 31:817-821. 被引量:1
  • 6Levy S, Brelthardt G, Campbell RW, et al. Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J, 1998, 19:1294-1320. 被引量:1
  • 7Antiplatelet Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J, 2000, 324:71-86. 被引量:1
  • 8Hsievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation, 2002, 105:1887-1891. 被引量:1
  • 9Ezekowita MD, Levine JA. Preventing stoke in patients with atrial fibrillation. JAMA, 1999, 281: 1830-1835. 被引量:1
  • 10Fuller R.Anticoagulation to prevent strokes in older people with atrial fibrillation:assembling individualized risk and benefit information[J].J Am Geriatr Soc,2004,52 (11):1968. 被引量:1

共引文献64

同被引文献29

引证文献5

二级引证文献12

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈